Next Articles

Home » Health » Currently Reading:

The Company istargeting major central nervous system diseases including: Ischemic SpasticParaplegia Traumatic Spinal

June 16, 2010 Health No Comments

The Company istargeting major central nervous system diseases including: Ischemic SpasticParaplegia, Traumatic Spinal Cord Injury, Huntington`s disease and AmyotrophicLateral Sclerosis (ALS), often referred to as Lou Gehrig’s disease. About Midtown Partners & Co., LLCInformation on Midtown Partners can be found at http:// About Neuralstem, Inc.Neuralstem’s patented technology enables, for the first time, the ability toproduce neural stem cells of the human brain and spinal cord in commercialquantities, and the ability to control the differentiation of these cells intomature, physiologically relevant human neurons and glia. About Vicis Capital, LLCVicis Capital Master Fund, a sub-trust of Vicis Capital Series Master Trust(Vicis), is a multi-strategy hedge fund focusing on equity volatility arbitrageand convertible arbitrage, with expertise in quantitative, fundamental, macroand situation-specific analysis. Weappreciate Vicis` show of commitment to our vision and business model.” Midtown Partners & Co., LLC, a FINRA member & SIPC Broker/Dealer served asexclusive placement agent for the offering. We are confident in the company`s leadership position to treatneurodegenerative conditions and injury with its cells.” Richard Garr, President and CEO of Neuralstem, stated, “These funds will help tosupport the development of our stem cell technology including the pre-clinicalwork at the China Medical University & Hospital of Taiwan on stroke. ROCKVILLE, Md.–(Business Wire)–Neuralstem, Inc.

(NYSE Amex:CUR) announced today that Vicis Capital Master Fundhas purchased 800,000 shares of Neuralstem common stock at $1.25 per share,reflecting an approximate 20% premium to the closing price of the stock onMonday, June 29. The Company also issued to Vicis warrants to purchase 2.4million shares of Neuralstem common stock at $1.25 a share, a third of whichmust be exercised within a year from the date of issuance, a third within threeyears, and the final third within five years from the date of issuance.Neuralstem plans to use these proceeds for working capital. Vicis Capital Managing Director Chris Phillips stated, “We are very excited tocomplete this transaction as we believe this is a strong investment for ourportfolio. Various risks anduncertainties may affect the Company and its results of operations, as describedin reports filed by the Company with the Securities and Exchange Commission fromtime to time. The Company does not assume any obligation to update theseforward-looking statements.IncrediMail NYJeff Holzmann, orKCSA Strategic CommunicationsTodd Fromer, Marybeth Csaby, Copyright Business Wire 2009. The words “believe,” “expect,” “intend,” “plan,” “should” andsimilar expressions are intended to identify forward-looking statements. Suchstatements reflect the current views, assumptions and expectations of theCompany with respect to future events and are subject to risks anduncertainties.

Many factors could cause the actual results, performance orachievements of the Company to be materially different from any future results,performance or achievements that may be expressed or implied by suchforward-looking statements, including, among others, changes in the markets inwhich the Company operates and in general economic and business conditions, lossof key customers and unpredictable sales cycles, competitive pressures, marketacceptance of new products, inability to meet efficiency and cost reductionobjectives, changes in business strategy and various other factors, bothreferenced and not referenced in this press release. Forward-Looking StatementsThis press release contains historical information and forward-lookingstatements within the meaning of The Private Securities Litigation Reform Act of1995 with respect to the business, financial condition and results of operationsof the Company. Other products include, HiYo agraphic add-on to instant messaging software, Magentic, a wallpaper andscreensaver software, and PhotoJoy, software for presenting digital personalphotos. It alsoreaffirms our commitment to our current business model that we believe hasdemonstrated our approach to monetizing our user base is clearly working.” About IncrediMail Ltd.IncrediMail Ltd. (NASDAQ: MAIL) is an internet company that develops customized,downloadable graphic consumer applications used to generate search relatedrevenues and designs, markets and delivers high end personal desktop software.The company`s award winning e-mail client product, IncrediMail Premium, is soldin over 100 countries in 10 different languages. “The contract renewal facilitates our currentbusiness strategy, which allows IncrediMail users to carry out `Googlesearches`, will continue to move forward for another two years.

Comment on this Article:

You must be logged in to post a comment.

Related Articles: